MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

L. Ostrosky-Zeichner; S. Shoham; J. Vazquez; A. Reboli; R. Betts; M. A. Barron; M. Schuster; M. A. Judson; S. G. Revankar; J. P. Caeiro; J. E. Mangino; D. Mushatt; R. Bedimo; A. Freifeld; M. H. Nguyen; C. A. Kauffman; W. E. Dismukes; A. O. Westfall; J. B. Deerman; C. Wood; J. D. Sobel; P. G. Pappas

doi:10.1093/cid/ciu074

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

Clinical Infectious Diseases ◽

10.1093/cid/ciu074 ◽

2014 ◽

Vol 58 (9) ◽

pp. 1219-1226 ◽

Cited By ~ 98

Author(s):

L. Ostrosky-Zeichner ◽

S. Shoham ◽

J. Vazquez ◽

A. Reboli ◽

R. Betts ◽

...

Keyword(s):

Critical Care ◽

High Risk ◽

Invasive Candidiasis ◽

Care Setting ◽

Controlled Trial ◽

Critical Care Setting ◽

Preemptive Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718281739.793502937 ◽

2015 ◽

Author(s):

Jean-Francois Timsit

Keyword(s):

Critical Care ◽

High Risk ◽

Invasive Candidiasis ◽

Care Setting ◽

Controlled Trial ◽

Critical Care Setting ◽

Preemptive Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v68n0519 ◽

2007 ◽

Vol 68 (05) ◽

pp. 781-788 ◽

Cited By ~ 77

Author(s):

Robert L. Findling ◽

Thomas W. Frazier ◽

Eric A. Youngstrom ◽

Nora K. McNamara ◽

Robert J. Stansbrey ◽

...

Keyword(s):

Bipolar Disorder ◽

High Risk ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-Blind, Placebo-Controlled Trial of a Herpes Simplex Virus Type 2 Glycoprotein Vaccine in Persons at High Risk for Genital Herpes Infection

The Journal of Infectious Diseases ◽

10.1093/infdis/161.4.653 ◽

1990 ◽

Vol 161 (4) ◽

pp. 653-660 ◽

Cited By ~ 96

Author(s):

G. J. Mertz ◽

R. Ashley ◽

R. L. Burke ◽

J. Benedetti ◽

C. Critchlow ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

High Risk ◽

Genital Herpes ◽

Herpes Simplex Virus Type ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Simplex Virus

Download Full-text

OC01.04: Aspirin versus placebo in pregnancies at high-risk of preterm pre-eclampsia: a multicentre, double-blind, placebo-controlled trial

Ultrasound in Obstetrics and Gynecology ◽

10.1002/uog.17573 ◽

2017 ◽

Vol 50 ◽

pp. 2-2 ◽

Cited By ~ 2

Author(s):

D. Rolnik ◽

D. Wright ◽

L. Poon ◽

N. O'Gorman ◽

A. Syngelaki ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

European Heart Journal ◽

10.1093/eurheartj/ehs023 ◽

2012 ◽

Vol 33 (9) ◽

pp. 1142-1149 ◽

Cited By ~ 139

Author(s):

Maartje E. Visser ◽

Gilbert Wagener ◽

Brenda F. Baker ◽

Richard S. Geary ◽

Joanne M. Donovan ◽

...

Keyword(s):

High Risk ◽

Apolipoprotein B ◽

Controlled Trial ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Synthesis Inhibitor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Invasive candidiasis in critical care setting, updated recommendations from “Invasive Fungal Infections-Clinical Forum”, Iran

World Journal of Critical Care Medicine ◽

10.5492/wjccm.v3.i4.102 ◽

2014 ◽

Vol 3 (4) ◽

pp. 102 ◽

Cited By ~ 1

Author(s):

Ashraf Elhoufi

Keyword(s):

Critical Care ◽

Invasive Candidiasis ◽

Care Setting ◽

Fungal Infections ◽

Invasive Fungal Infections ◽

Critical Care Setting

Download Full-text

Aprepitant, a Neurokinin-1 Receptor Antagonist, for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Randomized, Double-blind, Placebo Controlled Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-00133 ◽

2011 ◽

Vol 106 ◽

pp. S54

Author(s):

Tilak Shah ◽

Martin Poleski ◽

Stanley Branch ◽

Paul Jowell ◽

Jorge Obando ◽

...

Keyword(s):

High Risk ◽

Receptor Antagonist ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Neurokinin 1 Receptor ◽

High Risk Patients ◽

Risk Patients ◽

Neurokinin 1

Download Full-text

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial

BMC Cancer ◽

10.1186/s12885-018-4275-z ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 4

Author(s):

Lorenzo Tosco ◽

◽

Annouschka Laenen ◽

Thomas Gevaert ◽

Isabelle Salmon ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trial

ACC Current Journal Review ◽

10.1016/j.accreview.2004.08.105 ◽

2004 ◽

Vol 13 (10) ◽

pp. 17

Author(s):

H.C. Diener ◽

J. Bogousslavsky ◽

L.M. Brass

Keyword(s):

Ischemic Stroke ◽

High Risk ◽

Transient Ischemic Attack ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Ischemic Attack

Download Full-text

Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.08.023 ◽

2007 ◽

Vol 29 (8) ◽

pp. 1579-1590 ◽

Cited By ~ 31

Author(s):

Craig LaForce ◽

Choy Y. Man ◽

Frederick W. Henderson ◽

Janet E. McElhaney ◽

Frank C. Hampel ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Community Dwelling ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text